These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36698323)
1. An updated patent review of glutaminase inhibitors (2019-2022). Wang D; Li X; Gong G; Lu Y; Guo Z; Chen R; Huang H; Li Z; Bian J Expert Opin Ther Pat; 2023 Jan; 33(1):17-28. PubMed ID: 36698323 [TBL] [Abstract][Full Text] [Related]
2. Glutaminase inhibitors: a patent review. Wu C; Chen L; Jin S; Li H Expert Opin Ther Pat; 2018 Nov; 28(11):823-835. PubMed ID: 30273516 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, structure-activity relationship studies, and evaluation of novel GLS1 inhibitors. Jo M; Koizumi K; Suzuki M; Kanayama D; Watanabe Y; Gouda H; Mori H; Mizuguchi M; Obita T; Nabeshima Y; Toyooka N; Okada T Bioorg Med Chem Lett; 2023 May; 87():129266. PubMed ID: 37011768 [TBL] [Abstract][Full Text] [Related]
4. Targeting GLS1 to cancer therapy through glutamine metabolism. Yu W; Yang X; Zhang Q; Sun L; Yuan S; Xin Y Clin Transl Oncol; 2021 Nov; 23(11):2253-2268. PubMed ID: 34023970 [TBL] [Abstract][Full Text] [Related]
5. Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease. Soomro I; Sun Y; Li Z; Diggs L; Hatzivassiliou G; Thomas AG; Rais R; Parker SJ; Slusher BS; Kimmelman AC; Somlo S; Skolnik EY Nephrol Dial Transplant; 2018 Aug; 33(8):1343-1353. PubMed ID: 29420817 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer. Udupa S; Nguyen S; Hoang G; Nguyen T; Quinones A; Pham K; Asaka R; Nguyen K; Zhang C; Elgogary A; Jung JG; Xu Q; Fu J; Thomas AG; Tsukamoto T; Hanes J; Slusher BS; Cooper AJL; Le A Proteomics; 2019 Nov; 19(21-22):e1800451. PubMed ID: 31231915 [TBL] [Abstract][Full Text] [Related]
7. Glutaminase 1 plays a key role in the cell growth of fibroblast-like synoviocytes in rheumatoid arthritis. Takahashi S; Saegusa J; Sendo S; Okano T; Akashi K; Irino Y; Morinobu A Arthritis Res Ther; 2017 Apr; 19(1):76. PubMed ID: 28399896 [TBL] [Abstract][Full Text] [Related]
8. Genetic Pharmacotherapy as an Early CNS Drug Development Strategy: Testing Glutaminase Inhibition for Schizophrenia Treatment in Adult Mice. Mingote S; Masson J; Gellman C; Thomsen GM; Lin CS; Merker RJ; Gaisler-Salomon I; Wang Y; Ernst R; Hen R; Rayport S Front Syst Neurosci; 2015; 9():165. PubMed ID: 26778975 [TBL] [Abstract][Full Text] [Related]
9. Glutaminase (GLS1) gene expression in primary breast cancer. Vidula N; Yau C; Rugo HS Breast Cancer; 2023 Nov; 30(6):1079-1084. PubMed ID: 37679553 [TBL] [Abstract][Full Text] [Related]
11. Targeting glutaminase 1 (GLS1) by small molecules for anticancer therapeutics. Chen Y; Tan L; Gao J; Lin C; Wu F; Li Y; Zhang J Eur J Med Chem; 2023 Apr; 252():115306. PubMed ID: 36996714 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of novel glutaminase 1 allosteric inhibitors with an alkane chain tail group. Chang X; Wang M; Zhang D; Zhang Y; Wang J; Li Z; Bian J; Xu X Eur J Med Chem; 2023 Jan; 246():115014. PubMed ID: 36525694 [TBL] [Abstract][Full Text] [Related]
13. The metabolic importance of the glutaminase II pathway in normal and cancerous cells. Dorai T; Pinto JT; Denton TT; Krasnikov BF; Cooper AJL Anal Biochem; 2022 May; 644():114083. PubMed ID: 33352190 [TBL] [Abstract][Full Text] [Related]
14. Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer. Pan T; Gao L; Wu G; Shen G; Xie S; Wen H; Yang J; Zhou Y; Tu Z; Qian W Biochem Biophys Res Commun; 2015 Jan; 456(1):452-8. PubMed ID: 25482439 [TBL] [Abstract][Full Text] [Related]
15. Structure-Enabled Discovery of Novel Macrocyclic Inhibitors Targeting Glutaminase 1 Allosteric Binding Site. Xu X; Wang J; Wang M; Yuan X; Li L; Zhang C; Huang H; Jing T; Wang C; Tong C; Zhou L; Meng Y; Xu P; Kou J; Qiu Z; Li Z; Bian J J Med Chem; 2021 Apr; 64(8):4588-4611. PubMed ID: 33792311 [TBL] [Abstract][Full Text] [Related]
16. Novel allosteric glutaminase 1 inhibitors with macrocyclic structure activity relationship analysis. Lee EJ; Duggirala KB; Lee Y; Yun MR; Jang J; Cyriac R; Jung ME; Choi G; Chae CH; Cho BC; Lee K Bioorg Med Chem Lett; 2022 Nov; 75():128956. PubMed ID: 36038117 [TBL] [Abstract][Full Text] [Related]
17. Filamentous GLS1 promotes ROS-induced apoptosis upon glutamine deprivation via insufficient asparagine synthesis. Jiang B; Zhang J; Zhao G; Liu M; Hu J; Lin F; Wang J; Zhao W; Ma H; Zhang C; Wu C; Yao L; Liu Q; Chen X; Cao Y; Zheng Y; Zhang C; Han A; Lin D; Li Q Mol Cell; 2022 May; 82(10):1821-1835.e6. PubMed ID: 35381197 [TBL] [Abstract][Full Text] [Related]
18. Discovery of novel glutaminase 1 allosteric inhibitor with 4-piperidinamine linker and aromatic heterocycles. Xu X; Chang X; Huang J; Zhang D; Wang M; Jing T; Zhuang Y; Kou J; Qiu Z; Wang J; Li Z; Bian J Eur J Med Chem; 2022 Jun; 236():114337. PubMed ID: 35428013 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism. Huang Q; Stalnecker C; Zhang C; McDermott LA; Iyer P; O'Neill J; Reimer S; Cerione RA; Katt WP J Biol Chem; 2018 Mar; 293(10):3535-3545. PubMed ID: 29317493 [TBL] [Abstract][Full Text] [Related]
20. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer. Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]